Your SlideShare is downloading. ×
Canonical Models for Large Molecules
Canonical Models for Large Molecules
Canonical Models for Large Molecules
Canonical Models for Large Molecules
Canonical Models for Large Molecules
Canonical Models for Large Molecules
Canonical Models for Large Molecules
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Canonical Models for Large Molecules

582

Published on

David Klatte (Pfizer) presented on this potential new working group during the "Dragons' Den" portion of the Pistoia Alliance Conference in Boston, MA, on April 24, 2012.

David Klatte (Pfizer) presented on this potential new working group during the "Dragons' Den" portion of the Pistoia Alliance Conference in Boston, MA, on April 24, 2012.

Published in: Technology, Art & Photos
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
582
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Dragon’s Den – David Klatte
  • 2. CTAB Files – A De Facto Standard
  • 3. Imagine a World Without MOL Chemical tools couldn’t talk to each other. CROs would require custom formats (or pharma companies would have to design a format and require it of them) Acquiring a large compound file would be a nightmare
  • 4. There Is A Better Way HELM: A Hierarchical Editing Language for Macromolecules  Intuitive, Hierarchical, Extensible, Computer Readable, Canonicalizable (and there are tools!)
  • 5. Why a Pistoia Standard? More complex than CTAB/MOL/SD. Extensible means there is more than one way to do things. One way needs to be agreed upon. Pistoia is best positioned to publicize a standard. A de facto standard for macromolecules would not work.
  • 6. ROI Pharma invests less time figuring out how to interact with CROs for macromolecules. Software companies have a representation they can use for interoperability. Tools already exist. Everything won’t need to be written from scratch. Most of the hard work has been done already. Let’s prove that Pistoia can create a standard.

×